Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
3SBio Inc. announced a $2.7 million writedown as a...
Charles River Labs noted a slowdown in the worldwide CRO...
3SBio Inc. (沈阳三生制药) has filed for SFDA...
China has enacted the third major revision of its patent...
3SBio Inc. (沈阳三生制药) announced that 2008...
aTyr Pharma will use a Hong Kong lab to help develop...
3SBio Inc. (沈阳三生制药)reported that Q2 revenues...
Cheezheng Tibetan Medicine was approved to IPO on the...
3SBio Inc. applied to the SFDA to begin a registrational...
Beijing announced a 10 billion RMB ($1.5 billion) fund to...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
